Moscow is the first international forum of Oncology and radiology. Mmeropriatia, which is attended by over 2,500 specialists from Russia and abroad, dedicated to the 120th anniversary of the Moscow research oncological Institute. P. A. Herzen. A large-scale research program and a special, interdisciplinary, comprehensive format covers almost all the areas and aspects of Oncology.
In the framework of the forum are restricted subject 11 congresses, including encourtered, neuro-Oncology, photodynamic therapy, organization of health care and nursing in Oncology. Special attention is paid to educational component for the first time in Russia held a ESTRO school (European society of specialists in radiology, and Oncology) on topical issues of radiation therapy.
The debate that erupted in the Congress and healthcare professionals in Oncology related to the structure of oncologic service in Russia, analyzing the duration of treatment from the onset of diagnosis, and consideration of patients with malignant neoplasms in the Federal cancer registry. According to the chief oncologist of Ministry of health, General Director of SMRC radiologista Kaprina, official data on mortality from cancer may be incomplete. In particular due to the fact that experts do not always see the real picture: Oncology have not received information about the part the dead at home, still high and the percentage of diagnoses that are exhibited posthumously.
Oncological service in Russia, successfully operating since 1945, but its structure is outdated and requires revision, noted the participants of the Congress.In particular, cancer care is often referred to drug and radiation therapy, and surgery goes to a different area of responsibility. This situation does not take into account the nature of the disease and may not have a beneficial effect on the patient, including, for sick children.Like the fact that the regulatory framework for lifetime morphological diagnostics are sorely far from the realities of today when it is the conclusion of the pathologists ‘ for oncologists becomes the main guide for decisions on further treatment tactics.